Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration (wAMD)”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableLooking for participantsNCT06859515
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 42
Testing effectiveness (Phase 2)Study completedNCT03558074
What this trial is testing

Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 26
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Testing effectiveness (Phase 2)Looking for participantsNCT07630649
What this trial is testing

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Adverum Biotechnologies, Inc. 15
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Large-scale testing (Phase 3)UnknownNCT05480293
What this trial is testing

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 446
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839339
What this trial is testing

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 40
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Post-approval studies (Phase 4)Study completedNCT02246829
What this trial is testing

Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START

Who this might be right for
Neovascular Age-related Macular Degeneration of All Subtypes
University Hospital, Bordeaux 50
Testing effectiveness (Phase 2)Study completedNCT04832724
What this trial is testing

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular DegenerationWet Age-related Macular Degeneration
AbbVie 60
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Not applicableStudy completedNCT01933152
What this trial is testing

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 137
Large-scale testing (Phase 3)Study completedNCT04740671
What this trial is testing

Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Who this might be right for
Age Related Macular Degeneration
Shanghai Henlius Biotech 410
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 311
Not applicableActive Not RecruitingNCT04932980
What this trial is testing

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Berner Augenklinik 80
Not applicableStudy completedNCT01899963
What this trial is testing

Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot Study

Who this might be right for
Wet Age Related Macular DegenerationDiabetic Macular Edema
McMaster University 83
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Not applicableLooking for participantsNCT06718816
What this trial is testing

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Next Page